Calyxo
1 known investors
Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared. The company serves urologists and patients seeking routine, single-treatment kidney stone management.
HealthtechMedical Devices
Founders & leadership
J
JoePresident and Chief Executive Officer
J
JeeFounder and Chief Business Officer
Investors · 1
In the news
- Careers - Calyxocalyxoinc.com · 2026
- Calyxo raises $40m to advance kidney stone removal systemfinance.yahoo.com · 2026
- Calyxo Secures $40 Million Series F Financing as CVAC System Surpasses 40,000 Patients Treated for Kidney Stone Removalbusinesswire.com · 2026
- Calyxo Secures $40M in Series F Fundingfinsmes.com · 2026
- Sell or Invest in Calyxo Stock Pre-IPOnasdaqprivatemarket.com · 2025
- Calyxo Raises $50M in Series D Fundingfinsmes.com · 2023